The ATM is proud to share that Dr. Dean Regier is the lead author on the recently-published article ‘A perspective on life-cycle health technology assessment and real-world evidence for precision oncology in Canada’.
Dr. Regier is Associate Director of the ATM and also Chair of the ATM Regulatory Advisory Council. The authors also included instructors for the recently-completed ATM Regulatory Affairs in the Life Sciences micro-certificate courses led by Dr. Regier, including Dr. Samantha Pollard, Melanie McPhail, Dr. Tania Bubela, and Deirdre Weymann. Please join us in congratulating them all, and by reading about the success of the micro-certificates here.
To better understand what precision oncology is and how the framework developed by these researchers contributes to this important work click here.